Sirona Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Sirona Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 5, 2025	OTR Therapeutics	$100.0M Series A	—	Yi Shi, TrueLight Capital
Oct 1, 2025	Kailera Therapeutics	$600.0M Series B	Andrew Kaplan	Bain Capital, Gotham Makker, Michael Gladstone, Adage Capital Management, Atlas Venture, Bain Capital Life Sciences, Invus, Janus Henderson Investors, Perseverance Capital Management, Qatar Investment Authority, Royalty Pharma, Roderick Wong, Surveyor Capital, T. Rowe Price Associates
Dec 1, 2023	Synnovation Therapeutics	$100.0M Series A	Third Rock Ventures	Johnson & Johnson Innovation, Sofinnova Investments, Cormorant Asset Management, Judith Li, Thilo Schroeder, Ting Feng
Mar 27, 2023	ArriVent Biopharma	$155.0M Series B	Elena Viboch, James Healy	AIHC Capital, Catalio Capital Management, HBM Healthcare Investments, Hongshan Capital Group (Sequoia Capital China), Infinitum Asset Management, Lilly Asia Ventures, Octagon Capital, Carl Gordon, Shanghai Healthcare Capital, Terra Magnum Capital Partners, Unicorn Capital, Zoo Capital
Jan 1, 2023	ADARx Pharmaceuticals	$46.0M Series B	Lorence Kim	Andreessen Horowitz, Frazier Healthcare Partners, Ed Mathers, OrbiMed, SR One, Third Rock Ventures, Lilly Asia Ventures
Nov 15, 2022	CG Oncology	$120.0M Series E	Decheng Capital, Brian Liu, Simone Song	Acorn Bioventures, Ally Bridge Group, Malin Corporation, RA Capital Management
Nov 30, 2021	Fuse Biotherapeutics	$9.5M Seed	—	GC&H Investments, Ivy Venture Group, Darren Cai
Nov 1, 2021	Antiva Biosciences	$31.0M Series D	Adjuvant Capital	Canaan Partners, Johnson & Johnson Innovation, Osage University Partners, Alexandria Venture Investments, Avestria Ventures, Brace Pharma Capital, Canaan Partners, Dong-A ST, Gaingels, Google Ventures, HBM Healthcare Investments, Lumira Ventures, Mana Ventures, Sofinnova Ventures
Sep 1, 2021	ADARx Pharmaceuticals	$75.0M Series B	OrbiMed, SR One	Andreessen Horowitz, Frazier Healthcare Partners, Ed Mathers, Lilly Asia Ventures
Jul 1, 2018	Antiva Biosciences	$15.0M Series C	Hillhouse Capital Group	Canaan Partners, Johnson & Johnson Innovation, Osage University Partners, Brace Pharma Capital, Canaan Partners, Lumira Ventures, Sofinnova Ventures
Apr 9, 2018	Constellation Pharmaceuticals	$100.0M Other Equity	—	Casdin Capital, Cormorant Asset Management, Deerfield Management, Fidelity Management & Research Company, Hillhouse Capital, NS Investment, OrbiMed, SR One, The Column Group, Third Rock Ventures, Topspin Partners, University of California, Venrock
Apr 1, 2018	Arvinas	$55.0M Series C	Jakob Loven	5AM Ventures, Access Biotechnology, Andreessen Horowitz, Atlas Venture, Canaan Partners, Deerfield Management, Nextech Invest, OrbiMed, RA Capital, Versant Ventures, Canaan Partners, Hillhouse Capital, New Leaf Venture Partners, RA Capital Management
Mar 1, 2018	TCR2	$130.0M Series B	Li Wei, Curative Ventures	Creacion Ventures, MPM Capital, Osage University Partners, Alexandria Venture Investments, ArrowMark Partners, Cathay Fortune Capital Investment, F2 Ventures, Haitong International, Hillhouse Capital Group, Lucion Group, Mirae Asset, Redmile Group, Syno Capital
Feb 1, 2018	Viela Bio	$280.0M Series A	—	6 Dimensions Capital, Yanling Cao, Michael Yi, Temasek
Dec 1, 2017	Hookipa Pharma	$60.0M Series C	—	Boehringer Ingelheim Venture Fund, Soffinova Partners, BioMedPartners, Boehringer Ingelheim, Forbion, Gilead Sciences, HBM Partners, Hillhouse Capital, Takeda Ventures
Nov 29, 2017	Codiak Biosciences	$76.5M Series C	—	Alaska Permanent Fund, Alexandria Venture Investments, ARCH Venture Partners, Boxer Capital, Casdin Capital, EcoR1 Capital, Fidelity Management & Research Company, Flagship Pioneering, Qatar Investment Authority